“Sample collection holds a huge amount of untapped innovation potential. Obtaining specimens can be difficult for various emotional and technical reasons, and this appears to be particularly true of blood, urine, and stool samples. Exploration of this area should be firmly on the agenda of diagnostic companies looking to enter or expand the PoC space.”

Read the article by Sagentia Innovation’s Medical CTO, Dr Nick Collier in The Clinical Services Journal here.